MedCity News March 9, 2020
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
Every time you take a prescription medication, you are impacted by a clinical trial. From insulin to ibuprofen, every one of the more than 20,000 prescription medications currently on the market in the United States underwent controlled testing in human subjects prior to receiving approval by the U.S. Food and Drug Administration (FDA). The intent of clinical trials is to demonstrate the safety and effectiveness of a drug, yet poor study design may impede this process. This article highlights the need for the power of patient voice in the clinical design process.
Current clinical trial design
Most pharmaceutical...
Today's Sponsors
Today's Sponsor